At the time of writing, Context Therapeutics Inc [CNTX] stock is trading at $0.70, up 5.84%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CNTX shares have gain 19.54% over the last week, with a monthly amount drifted -9.09%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, JMP Securities started tracking the stock with Mkt Outperform rating on January 08, 2025, and set its price target to $4. On November 25, 2024, D. Boral Capital initiated with a Buy rating and assigned a price target of $9 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $4.50 on May 16, 2024.
For the past year, the stock price of Context Therapeutics Inc fluctuated between $0.49 and $2.75. Currently, Wall Street analysts expect the stock to reach $5.25 within the next 12 months. Context Therapeutics Inc [NASDAQ: CNTX] shares were valued at $0.70 at the most recent close of the market. An investor can expect a potential return of 650.0% based on the average CNTX price forecast.
Analyzing the CNTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.3 and Total Capital is -0.35. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6304 points at the first support level, and at 0.5578 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8071, and for the 2nd resistance point, it is at 0.9112.
Ratios To Look Out For
It is important to note that Context Therapeutics Inc [NASDAQ:CNTX] has a current ratio of 48.80. As well, the Quick Ratio is 48.80, while the Cash Ratio is 47.02.
